NABR Applauds CITES Committee's Decision on Cambodia's Long-Tailed Macaque Trade

On February 5, 2025, the National Association for Biomedical Research (NABR) expressed its appreciation toward the decision made by the CITES Standing Committee to not suspend the trade of long-tailed macaques (
Macaca fascicularis) from Cambodia. This resolution is seen as a pivotal acknowledgment of the importance of a fair, scientifically-backed evaluation process that emphasizes the need for thorough review and counters the spread of misinformation promoted by extremist activist groups.

Japan took the lead in urging the Standing Committee to delay any immediate decisions regarding the issue until future CITES meetings. Support for Japan's recommendation came from various convention parties including the United States, Canada, and Kuwait, showcasing a united front among countries that value a careful and well-considered approach to wildlife trade regulations.

During the meeting held in Geneva, Switzerland, not a single nation supported the Secretariat's recommendation to suspend trade based on unfounded claims surrounding the exportation of Khmer macaques. Instead, numerous countries, like Japan, Canada, and the US, voiced the critical need to examine new data presented by Cambodia before committing to any regulatory actions. The committee's decision ensures that the CITES Secretariat can conduct a rigorous assessment, including a delegation visit to Cambodia, thus maintaining transparency and fact-based decision-making.

Furthermore, this prudent strategy grants the House of Representatives' Committee on Natural Resources the necessary time to carry out a comprehensive review of the matter, reinforcing careful consideration in policy-making.

Matthew R. Bailey, the president of NABR, commented, "The NABR welcomes the Standing Committee's recognition that thorough, fact-based discussions are essential for decisions of such significance. Biomedical research relies heavily on the availability of long-tailed macaques to save human lives through the advancement of treatments for infectious diseases, cancer, and other critical medical issues. The international community's rejection of an unfounded suspension of trade signifies a significant victory for scientific credibility and public health."

NABR remains dedicated to promoting scientifically-informed policies that support ethical biomedical research and medical advancements. Bailey concluded, "We will continue collaborating with stakeholders globally to uphold transparency, scientific integrity, and responsible practices in the use of research animals for crucial medical studies."

About NABR

Established in 1979, the National Association for Biomedical Research (NABR) is the sole nonprofit 501(c)(6) organization dedicated to advocating for evidence-based policies that ensure the humane treatment of animals in biomedical research, education, and testing. With a membership of over 340 entities, including universities, medical and veterinary colleges, teaching hospitals, pharmaceutical and biotech companies, patient advocacy groups, and professional societies, NABR commits to promoting humane and responsible animal research for the health benefits of both humans and animals globally.

For more information, visit www.nabr.org.

For media inquiries, please contact Eva Maciejewski at (202) 967-8305 or via email at [email protected].